Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 70.64%
March 31, 2026 70.70%
December 31, 2025 70.46%
September 30, 2025 70.09%
June 30, 2025 68.76%
March 31, 2025 67.21%
December 31, 2024 68.50%
September 30, 2024 63.93%
June 30, 2024 65.59%
March 31, 2024 65.60%
December 31, 2023 65.22%
September 30, 2023 67.66%
June 30, 2023 62.32%
March 31, 2023 64.65%
December 31, 2022 64.28%
September 30, 2022 68.09%
June 30, 2022 66.65%
Date Value
March 31, 2022 64.85%
December 31, 2021 68.60%
September 30, 2021 67.56%
June 30, 2021 67.10%
March 31, 2021 66.22%
December 31, 2020 54.31%
September 30, 2020 66.55%
June 30, 2020 69.07%
March 31, 2020 63.22%
December 31, 2019 67.46%
September 30, 2019 62.30%
June 30, 2019 60.01%
March 31, 2019 54.15%
December 31, 2018 60.21%
September 30, 2018 62.10%
June 30, 2018 59.94%
March 31, 2018 53.42%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%
Baxter International, Inc. 33.55%

Gross Profit Margin (Quarterly) Related Metrics